Zhenyu Xu

机构：China Pharmaceutical University · ORCID：0000-0002-3484-9147

发表论文 73 篇 · 总被引 1782 次 · h-index 26

代表论文

Seizing the fate of lymph nodes in immunotherapy: To preserve or not? (2024 · Cancer Letters · 被引 30)
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer (2022 · Drug Delivery · 被引 28)
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer (2024 · Advanced Science · 被引 27)
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles (2023 · Cell Reports Medicine · 被引 22)
Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy (2025 · Acta Pharmaceutica Sinica B · 被引 15)
Interferon-γ priming enhances the therapeutic effects of menstrual blood-derived stromal cells in a mouse liver ischemia-reperfusion model (2023 · World Journal of Stem Cells · 被引 8)